Literature DB >> 19137481

Problem severity and motivation for treatment in incarcerated substance abusers.

Matthew L Hiller1, Egle Narevic, J Matthew Webster, Paul Rosen, Michele Staton, Carl Leukefeld, Thomas F Garrity, Rebecca Kayo.   

Abstract

Studies of community-based treatment programs for substance users document that motivation for treatment is a consistent predictor of clients remaining under treatment for a longer period of time. Recent research has replicated this in prison-based treatment programs, implying that motivation is clinically important regardless of setting. The current study examines predictors of treatment motivation using data collected from 661 male drug-involved inmates during in-depth interviews that include components of the Addiction Severity Index, TCU Motivation Scale, and the Heath Services Research Instrument. Findings showed treatment motivation can be measured effectively in prison-based settings. Motivation scores were not significantly different between individuals in a prison-based treatment program and those in the general prison population. Furthermore, higher motivation for treatment scores were associated with greater levels of problem severity, suggesting that individuals with more drug-use related life problems may recognize this need and desire help for beginning long-term recovery.

Mesh:

Year:  2009        PMID: 19137481     DOI: 10.1080/10826080802523301

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  11 in total

1.  A Pilot Study of a Brief Motivational Intervention for Incarcerated Drinkers.

Authors:  Mandy D Owens; Barbara S McCrady
Journal:  J Subst Abuse Treat       Date:  2016-05-26

2.  Influence of perceived coercion and motivation on treatment completion and re-arrest among substance-abusing offenders.

Authors:  Michael Prendergast; Lisa Greenwell; David Farabee; Yih-Ing Hser
Journal:  J Behav Health Serv Res       Date:  2008-05-31       Impact factor: 1.505

3.  Predictors of motivation for abstinence at the end of outpatient substance abuse treatment.

Authors:  Alexandre B Laudet; Virginia Stanick
Journal:  J Subst Abuse Treat       Date:  2010-02-25

4.  A Randomized Clinical Trial of Methadone Maintenance for Prisoners: Prediction of Treatment Entry and Completion in Prison.

Authors:  Michael S Gordon; Timothy W Kinlock; Kathryn A Couvillion; Robert P Schwartz; Kevin O'Grady
Journal:  J Offender Rehabil       Date:  2012-05-01

5.  Perceived Risk of HIV Infection Among Drug-Using African American Male Prisoners: One Year After Community Re-entry.

Authors:  Joi-Sheree' Knighton; Danelle Stevens-Watkins; Carrie Oser; Sycarah Fisher; Carlos C Mahaffey; Candice Crowell; Carl Leukefeld
Journal:  Subst Use Misuse       Date:  2016-08-02       Impact factor: 2.164

6.  Predictive validity of the SOCRATES in a clinical sample of Latina/o adolescents.

Authors:  Jason J Burrow-Sánchez; Carolina Corrales; Jessica Totsky
Journal:  Psychol Addict Behav       Date:  2018-12-27

7.  Life After: Examining the Relationship Between Sociobehavioral Factors and Mental Health Among African American Ex-Offenders.

Authors:  Carlos C Mahaffey; Danelle Stevens-Watkins; Carl Leukefeld
Journal:  Int J Offender Ther Comp Criminol       Date:  2018-01-02

8.  Motivation and readiness for drug treatment: differences by modality and special populations.

Authors:  Gerald Melnick; Josephine Hawke; George De Leon
Journal:  J Addict Dis       Date:  2014

9.  The Impact of Acculturation, Motivation and the Therapeutic Alliance on Treatment Retention and Outcomes for Hispanic Drug Involved Probationers.

Authors:  Jo Brocato
Journal:  J Ethn Crim Justice       Date:  2013-01-01

10.  Assessment of Japanese stimulant control law offenders using the Addiction Severity Index--Japanese version: comparison with patients in treatment settings.

Authors:  Takashi Watanabe; Yasukazu Ogai; Takehiro Koga; Eiichi Senoo; Kazuhiko Nakamura; Norio Mori; Kazutaka Ikeda
Journal:  Int J Environ Res Public Health       Date:  2009-12-03       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.